Skip to main content
. 2021 Jun 11;22(4):e53. doi: 10.4142/jvs.2021.22.e53

Fig. 1. Schematic diagram of the treatment schedule and the medium to induce adipogenic differentiation of cADSCs.

Fig. 1

cADSC, canine adipose-derived stem cell; qRT-PCR, quantitative real-time reverse-transcription polymerase chain reaction; FBS, fetal bovine serum; DMEM, Dulbecco's modified Eagle's medium; IBMX, 3-siobutyl-1-methylxanthine; MDI, 3-isobutyl-1-methylxanthine + dexamethasone + insulin; DRI, dexamethasone + rosiglitazone + insulin; MDRI, and 3-isobutyl-1-methylxanthine + dexamethasone + rosiglitazone + insulin.